The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-Benzo[b]thiophen-3-yl-4-(5-bromo-thiophen-2-yl)-pyrimidine ID: ALA3422864
PubChem CID: 118735948
Max Phase: Preclinical
Molecular Formula: C16H9BrN2S2
Molecular Weight: 373.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Brc1ccc(-c2ncncc2-c2csc3ccccc23)s1
Standard InChI: InChI=1S/C16H9BrN2S2/c17-15-6-5-14(21-15)16-11(7-18-9-19-16)12-8-20-13-4-2-1-3-10(12)13/h1-9H
Standard InChI Key: WEPDPPVJAYGHPS-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
4.2537 -4.1987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3443 -5.3916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8565 -5.2005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2781 -3.8165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1852 -2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6753 -2.8147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2104 -3.6248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9106 -2.3127 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.3842 -2.5929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5730 -4.0810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2161 -4.7204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2584 -1.7710 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 2 0
4 7 1 0
5 12 1 0
12 13 2 0
13 14 1 0
14 16 1 0
15 12 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
9 21 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.30Molecular Weight (Monoisotopic): 371.9391AlogP: 5.85#Rotatable Bonds: 2Polar Surface Area: 25.78Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 1.07CX LogP: 5.32CX LogD: 5.32Aromatic Rings: 4Heavy Atoms: 21QED Weighted: 0.44Np Likeness Score: -1.60
References 1. Verbitskiy EV, Cheprakova EM, Slepukhin PA, Kravchenko MA, Skornyakov SN, Rusinov GL, Chupakhin ON, Charushin VN.. (2015) Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds., 97 [PMID:25982331 ] [10.1016/j.ejmech.2015.05.007 ]